CU-CPT17e is utilized in scientific research to investigate cancer cell mechanisms and the development of anti-cancer drugs. It is particularly employed in testing the efficacy and safety of novel compounds with potential to inhibit cancer cell growth. Furthermore, it is applied in studies of apoptosis, or programmed cell death, which plays a crucial role in controlling cancer cell proliferation. These investigations enhance understanding of molecular mechanisms and contribute to the advancement of more effective cancer treatments.